Management of Symptomatic Hypoglycemia with D10
Initial Treatment Protocol
- The American College of Medical Guidelines recommends administering titrated boluses of 5-10 grams of D10 (50-100 mL) every 1-2 minutes until the patient's symptoms resolve and blood glucose reaches 100-180 mg/dL 1
- A patient-specific formula can be used to guide total dosing: (100 − current blood glucose in mg/dL) × 0.2 grams = total dose of dextrose needed, with 98% of patients achieving target range within 30 minutes 1
- Blood glucose should be rechecked at 15 minutes after initial treatment, and repeat glucose measurement at 60 minutes, as the effect may be temporary 1
Maximum Continuous Infusion Rate (When Indicated)
- For prolonged hypoglycemia or insulin overdose, the maximum continuous infusion rate of D10 is 0.5 g/kg/hour (approximately 7 mg/kg/min), with a maximum rate of ~290 mL/hour of D10 for a 70 kg adult patient 1
- The maximum oxidation rate of glucose in stressed patients is 4-7 mg/kg/min, so infusion should not exceed 5 mg/kg/min to decrease risk of metabolic alterations 2
Critical Monitoring Requirements
- Blood glucose should be monitored every 1-2 hours during any ongoing dextrose infusion, with more frequent monitoring initially when starting continuous infusion 1, 3
- Serum potassium and sodium levels should be monitored carefully, as dextrose administration can cause electrolyte shifts 1
- The infusion rate should be titrated to maintain blood glucose between 100-180 mg/dL 1
Important Safety Considerations for Liver Dysfunction
- In patients with hepatic failure or acute hepatitis, reduced hepatic gluconeogenesis increases the risk of severe hypoglycemia, requiring more prolonged dextrose infusion and more frequent monitoring 2, 3
Critical Pitfalls to Avoid
- Reflexive full-dose administration of concentrated dextrose should be avoided, as rapid or repeated boluses have been associated with cardiac arrest and hyperkalemia 1, 3
- Dextrose infusion should not be abruptly discontinued in insulin overdose patients; instead, the infusion rate should be reduced by 50% over the final 30 minutes before discontinuing to prevent rebound hypoglycemia 1